Sensex Today | Nomura maintains ‘buy’ rating on Dr Lal Pathlabs, target price at Rs 4,000
#1 Q2 margin beat estimates
#2 Revenue growth, margin expansion levers intact
Dr Lal PathLabs was quoting at Rs 3,267.95, up Rs 130.90, or 4.17 percent.
It has touched an intraday high of Rs 3,289.00 and an intraday low of Rs 3,147.05.
It was trading with volumes of 21,104 shares, compared to its five day average of 5,864 shares, an increase of 259.88 percent.
In the previous trading session, the share closed up 1.56 percent or Rs 48.05 at Rs 3,137.05.
The share touched a 52-week high of Rs 3,542.60 and a 52-week low of Rs 2,295.10 on 19 September, 2025 and 03 March, 2025, respectively.
Currently, the stock is trading 7.75 percent below its 52-week high and 42.39 percent above its 52-week low.
Market capitalisation stands at Rs 27,377.42 crore.